Sordarin oxazepine derivatives as potent antifungal agents

Bioorganic and Medicinal Chemistry Letters

Volumn 12, Issue 19, 2002, Pages 2757-2760

  Serrano Wu, Michael H ^a   St Laurent, Denis R ^a   Chen, Yijun ^a   Huang, Stella ^a   Lam, Kin Ray ^a   Matson, James A ^a   Mazzucco, Charles E ^a   Stickle, Terry M ^a   Tully, Thomas P ^a   Wong, Henry S ^a   Vyas, Dolatrai M ^a   Balasubramanian, Balu N ^a  

^a BRISTOL MYERS SQUIBB   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIFUNGAL AGENT; OXAZEPINE DERIVATIVE; SORDARIN DERIVATIVE;

AMINATION; ANTIFUNGAL ACTIVITY; ARTICLE; CANDIDA ALBICANS; CANDIDA GLABRATA; CONTROLLED STUDY; CRYPTOCOCCUS NEOFORMANS; DRUG OXIDATION; DRUG POTENCY; DRUG SYNTHESIS; NONHUMAN; STEREOCHEMISTRY; STRUCTURE ACTIVITY RELATION;

ANTIBIOTICS, ANTIFUNGAL; CANDIDA ALBICANS; CANDIDA GLABRATA; CRYPTOCOCCUS NEOFORMANS; FUNGI; HYDROGEN BONDING; INDENES; MICROBIAL SENSITIVITY TESTS; OXAZEPINES; STRUCTURE-ACTIVITY RELATIONSHIP;

CANDIDA; CANDIDA ALBICANS; CANDIDA GLABRATA; FILOBASIDIELLA NEOFORMANS;

EID: 0037037371     PISSN: 0960894X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0960-894X(02)00529-2     Document Type: Article

References (25)

1. Hauser D., Sigg H.P. Helvetica Chim Acta. 54:1971;1178.
2. (a) Dominguez, J. M.; Martin, J. J. Antimicrob. Agents Chemother. 1998, 42, 2274.
3. (b) Capa, L.; Mendoza, A.; Lavandra, J. L.; Gomez de Las, H. F.; Garcia-Bustos, J. F. Antimicrob. Agents Chemother. 1998, 42, 2279.
4. (c) Justice, M. C.; Hsu, M. J.; Tse, B.; Ku, T.; Balkovec, J.; Schmatz, D.; Nielsen, J. J. Biol. Chem. 1998, 273, 3148.
5. For reviews, see (a) Odds F.C. Exp. Opin. Ther. Patents. 11:2001;283 (b) Ziegelbauer K., Spaltmann F. Drugs Future. 25:2000;63 (c) Gargolla-Viola D. Curr. Opin Anti-infective Invest. Drugs. 1:1999;297.
6. For reviews, see (a) Odds F.C. Exp. Opin. Ther. Patents. 11:2001;283 (b) Ziegelbauer K., Spaltmann F. Drugs Future. 25:2000;63 (c) Gargolla-Viola D. Curr. Opin Anti-infective Invest. Drugs. 1:1999;297.
7. For reviews, see (a) Odds F.C. Exp. Opin. Ther. Patents. 11:2001;283 (b) Ziegelbauer K., Spaltmann F. Drugs Future. 25:2000;63 (c) Gargolla-Viola D. Curr. Opin Anti-infective Invest. Drugs. 1:1999;297.
8. Dominguez J.M., Gomez-Lorenzo M.G., Martin J.J. J. Biol. Chem. 274:1999;22423.
9. (a) Arribas E.M., Castro J., Clemens I.R., Cuevas J.C., Chicharro J., Fraile T., Garcia-Ochoa S., Gomez de las Heras F., Ruiz J.R. Bioorg. Med. Chem. Lett. 12:2002;117
10. (b) Bueno J.M., Cuevas J.C., Fiandor J.M., Garcia-Ochoa S., Gomez de las Heras F. Bioorg. Med. Chem. Lett. 12:2002;121.
11. For reviews, see (a) Odds F.C. Exp. Opin. Ther. Patents. 11:2001;283 (b) Gargolla-Viola D. Curr. Opin. Anti-infective Invest. Drugs. 1:1999;297.
12. For reviews, see (a) Odds F.C. Exp. Opin. Ther. Patents. 11:2001;283 (b) Gargolla-Viola D. Curr. Opin. Anti-infective Invest. Drugs. 1:1999;297.
13. Herreros E., Almela M.J., Lozano S., Gomez de las Heras F., Gargolla-Viola D. Antimicrob. Agents Chemother. 45:2001;3132.
14. Serrano-Wu M.H., St. Laurent D.R., Mazzucco C.E., Stickle T.M., Barrett J.F., Vyas D.M., Balasubramanian B.N. Bioorg. Med. Chem. Lett. 12:2002;943.
15. Hall R.M., Dawson M.J., Jones C.A., Roberts A.D., Sidebottom P.J., Stead P., Taylor N.L. J. Antibiot. 54:2001;948.
16. Bueno J.M., Chicharro Gonzalo J., Coteron J., Cuevas J.C., Fiandor J.M., Mallo A. WO 9958512; Chem. Abstr. 131:1999;337207.
17. Tully, T. P.; Bergum, J. S.; Schwarz, S. R.; Durand, S. C.; Howell, J. M.; Cino, P. M.; manuscript in preparation.
18. This strain has been deposited with the ATCC for registration.
19. 3CN (1.0 equiv), and the reaction was allowed to stir overnight at room temperature. Aqueous workup afforded the crude reductive amination product which was deprotected (TBAF in THF, then 1 N HCl in MeOH) according to standard procedures. The final targets 4a-n were purified to homogeneity by silica gel chromatography.
20. For other examples of syn-selective oxidation of triols, see (a) Jeong L.S., Shinazi R.F., Beach J.W., Kim H.O., Nampalli S. J. Med. Chem. 36:1993;181 (b) Stache U., Radscheit K., Haede W., Fritsch W. Liebigs Ann. Chem. 2:1982;342.
21. For other examples of syn-selective oxidation of triols, see (a) Jeong L.S., Shinazi R.F., Beach J.W., Kim H.O., Nampalli S. J. Med. Chem. 36:1993;181 (b) Stache U., Radscheit K., Haede W., Fritsch W. Liebigs Ann. Chem. 2:1982;342.
22. -) 534.
23. The fungal strains used in this study were obtained from the American Type Culture Collection. MICs were determined according to National Committee for Clinical Laboratory Standards (NCCLS); NCCLS Document M27-A; NCCLS: Villanova, PA, 1997.
24. Tse B., Balkovec J.M., Blazey C.M., Hsu M., Nielsen J., Schmatz D. Bioorg. Med. Chem. Lett. 8:1998;2269.
25. Shastry M., Nielsen J., Ku T., Hsu M., Liberator P., Anderson J., Schmatz D., Justice M.C. Microbiology. 147:2001;383.